Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Cary Skinner

Physician Assistant, Medical Newburyport, MA Physician Assistant

NPI 1942653621 CMS profile 11121775

7 Graf Rd, Newburyport, MA 01950

Open in the dashboard

General payments

$2,904

140 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Cary Skinner of Newburyport, MA is reported in the CMS Open Payments database as having received $2,904 across 140 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $488 20
2024 General $490 21
2023 General $517 25
2022 General $615 29
2021 General $794 45

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Cary Skinner
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Cary Skinner were reported at $488. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Cary Skinner Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $794 $156 $41–$563 $132
2022 $615 $185 $55–$649 $149
2023 $517 $199 $58–$717 $160
2024 $490 $206 $62–$740 $164
2025 $488 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Novartis Pharmaceuticals Corporation $528 29 payments
  2. E.R. Squibb & Sons, L.L.C. $475 23 payments
  3. AstraZeneca Pharmaceuticals LP $361 15 payments
  4. Pfizer Inc. $335 16 payments
  5. Janssen Pharmaceuticals, Inc $315 19 payments
  6. Amgen Inc. $254 11 payments
  7. Novo Nordisk Inc $133 6 payments
  8. Kiniksa Pharmaceuticals, Ltd. $88 4 payments
  9. Philips Electronics North America Corporation $81 3 payments
  10. Esperion Therapeutics, Inc. $65 3 payments
  11. Other $269 11 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,904 140 payments
Products named General payments · program years 2021–2025
  1. ELIQUIS Cardiovascular $368 17 payments
  2. LEQVIO $357 19 payments
  3. XARELTO $315 19 payments
  4. VYNDAQEL $282 13 payments
  5. ELIQUIS Cardiovascular;Metabolic Disease $253 13 payments
  6. Repatha $222 9 payments
  7. WAINUA $199 6 payments
  8. ENTRESTO $155 9 payments
  9. Ozempic $133 6 payments
  10. FARXIGA $121 6 payments
  11. Other $871 45 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

612

Median for Physician Assistant: 241

Drug cost

$59,457

Median for Physician Assistant: $4,110

Branded share of claims

27.3%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 40 $49,892
Metoprolol Succinate Generic 92 $2,009
Isosorbide Mononitrate Er Isosorbide Mononitrate Brand 83 $1,317
Atorvastatin Calcium Generic 50 $1,038
Rosuvastatin Calcium Generic 32 $919
Clopidogrel Clopidogrel Bisulfate Brand 30 $894
Hydralazine Hcl Generic 35 $855
Lisinopril Generic 54 $726
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 14 $434
Simvastatin Generic 23 $256

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 7 billing codes

Paid by Medicare

$36,279

Medicare's payments for the services billed

Medicare patients

253

Average age 77

Services billed

680

132 women, 121 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Arthritis 48%
Atrial fibrillation 46%
Diabetes 25%
Chronic kidney disease 23%
Heart failure 20%
COPD 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 10 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Repatha
  • Amgen Inc. $132
$132 — —
LEQVIO
  • Novartis Pharmaceuticals Corporation $81
$81 — —
CAMZYOS
  • E.R. Squibb & Sons, L.L.C. $57
$57 — —
XARELTO
  • Janssen Pharmaceuticals, Inc $56
$56 — —
FARXIGA
  • AstraZeneca Pharmaceuticals LP $42
$42 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 10 in the dashboard with a free account

Records

140 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record